Article

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials-05-01-2011
Volume20
Issue 5

Applied Clinical Trials Digital Edition - May 2011, Supplement

Oncology & Clinical Trials in the 21st Century CAM Use in Asia-Pacific Personalized Medicine Cancer Biomedical Informatics Grid How CROs Help Oncology Sponsors

External Link - article-821540.pdf

Download Issue PDF
Articles in this issue
Applied Clinical Trials Digital Edition - May 2011
Applied Clinical Trials Digital Edition - May 2011, Supplement
i4-721604-1408619907188.gif
GCLP: an Industry Perspective
i1-719552-1408621802915.jpg
Innovation is in for EU's Healthcare System
i1_t-719557-1408621766993.gif
Study Completion Times
i4-719540-1408621872327.jpg
Business and News Update May 2011

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
© Matthieu - © Matthieu - stock.adobe.com
August 9th 2025

Zusduri Demonstrates Sustained Efficacy in Phase III ENVISION Trial for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Andy Studna, Senior Editor
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 9th 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
© Kaikoro - © Kaikoro - stock.adobe.com
August 9th 2025

AI-Powered Non-Interventional Research Delivers What DCTs Promised

Troy Astorino
Unifying Industry to Better Understand GCP Guidance
August 9th 2025

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
© Satjawat - © Satjawat - stock.adobe.com
August 9th 2025

Tegoprazan Shows Superior Maintenance of Healing in Phase III TRIUMpH Study of Gastroesophageal Reflux Disease

Andy Studna, Senior Editor
Credit: Lars Neumann | stock.adobe.com
August 9th 2025

FDA Supports Continued Development of Eftilagimod Alfa in PD-L1–Negative Head and Neck Cancer

Andy Studna, Senior Editor
© 2025 MJH Life Sciences

All rights reserved.